BIOCRYST PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.16 USD | 0.00% |
|
-6.09% | -30.55% |
Chart calendar BioCryst Pharmaceuticals, Inc.
01ddb5f5d56fcd33.Tww8rzpe4xd1yuoNdGvTBsV2ea1OQV9gXdzhG3Ufxlg.BU8L6FVsoXkfv5w7JDyfd59OHsAWKzhNbPG3WhcmgmkVe1v5TDuXZyXyow~6bfa17cf50eb64a553379c2d6eeff50d
Upcoming events on BioCryst Pharmaceuticals, Inc.
Past events on BioCryst Pharmaceuticals, Inc.
| 09/04/2024 15:15 | Needham Healthcare Conference |
| 28/03/2024 18:30 | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 12/03/2024 11:30 | Barclays Global Healthcare Conference |
| 06/03/2024 15:30 | TD Cowen Health Care Conference |
| 26/02/2024 13:30 | Q4 2023 Earnings Call |
| 26/02/2024 12:00 | Q4 2023 Earnings Release |
| 24/02/2024 14:45 | American Academy of Allergy, Asthma & Immunology Meeting - Poster No : 281 |
| 23/02/2024 20:15 | American Academy of Allergy, Asthma & Immunology Meeting - Poster No : 023 |
| 23/02/2024 20:15 | American Academy of Allergy, Asthma & Immunology Meeting - Poster No : 028 |
| 23/02/2024 20:15 | American Academy of Allergy, Asthma & Immunology Meeting - Poster No : 008 |
| 23/02/2024 20:15 | American Academy of Allergy, Asthma & Immunology Meeting - Poster No :012 |
| 09/01/2024 23:00 | JPMorgan Healthcare Conference |
| 29/11/2023 17:30 | Piper Sandler Healthcare Conference |
| 28/11/2023 14:35 | Evercore ISI HealthCONx Conference |
| 11/11/2023 20:05 | American College of Allergy Asthma & Immunology Scientific Meeting - ePoster #P064 |
| 11/11/2023 01:30 | American College of Allergy Asthma & Immunology Scientific Meeting - ePoster #P082 |
| 03/11/2023 17:00 | R&D Day |
| 02/11/2023 12:30 | Q3 2023 Earnings Call |
| 02/11/2023 11:00 | Q3 2023 Earnings Release |
| 13/09/2023 17:30 | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 48,8 18,9 158.11% | 17,8 26,6 -33.08% | 157 160 -2.04% | 271 264 2.45% | 331 328 0.92% | 395 |
|
EBITDA Million USD | Released Forecast Spread | -98,7 -114 13.73% | -174 -165 -5.19% | -177 -179 0.91% | -147 -145 -1.6% | -102 -101 -1% | -56,0 |
|
EBIT Million USD | Released Forecast Spread | -99,5 -126 21.22% | -175 -165 -5.83% | -178 -170 -4.49% | -148 -122 -21.94% | -104 -83,5 -24.27% | -43,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -109 -136 19.81% | -183 -166 -10.08% | -182 -223 18.46% | -244 -205 -19.08% | -226 -192 -17.8% | -138 |
|
Net income Million USD | Released Forecast Spread | -109 -136 19.79% | -183 -166 -10.02% | -184 -224 17.84% | -247 -206 -19.81% | -227 -193 -17.14% | -128 |
|
EPS USD | Released Forecast Spread | -0,94 -1,22 22.64% | -1,09 -1,00 -8.93% | -1,03 -1,24 17.24% | -1,33 -1,13 -17.68% | -1,18 -1,06 -11.81% | -0,63 |
| Announcement Date | 05/03/20 | 25/02/21 | 23/02/22 | 21/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 47,2 50,5 -6.58% | 49,9 51,4 -2.8% | 65,5 63,8 2.67% | 75,8 74,8 1.4% | 79,5 74,2 7.23% | 68,8 71,4 -3.72% | 82,5 81,4 1.3% | 86,7 86,1 0.8% | 93,4 90,0 3.78% | 85,5 | 98,3 | 103 | 109 | 105 |
|
EBITDA Million USD | Released Forecast Spread | -52,0 -52,0 -0.01% | -49,6 -65,0 23.63% | -34,4 -55,0 37.48% | -17,1 -50,0 65.89% | -45,9 -47,0 2.31% | -28,0 -43,0 34.85% | -42,2 -41,0 -3.04% | |||||||
|
EBIT Million USD | Released Forecast Spread | -52,2 -44,1 -18.31% | -50,0 -56,5 11.53% | -34,7 -46,3 25.03% | -17,4 -32,1 45.65% | -46,3 -24,4 -89.75% | -28,4 -30,9 8.06% | -20,7 -21,4 3.07% | -11,9 -20,2 40.95% | -42,7 -21,6 -97.98% | -22,6 | -9,97 | -6,22 | -4,77 | -1,94 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,5 -57,0 72.74% | -73,9 -74,3 0.47% | -58,0 -68,2 14.92% | -41,0 -58,1 29.41% | -71,5 -51,2 -39.46% | -52,7 -53,5 1.48% | -74,6 -43,3 -72.1% | -35,8 -41,8 14.34% | -63,2 -42,6 -48.33% | -44,6 | -32,4 | -29,2 | -28,5 | -19,7 |
|
Net income Million USD | Released Forecast Spread | -17,8 -57,0 68.79% | -74,2 -74,5 0.39% | -58,9 -64,9 9.24% | -42,5 -54,6 22.12% | -71,5 -39,2 -82.5% | -53,3 -55,3 3.5% | -75,3 -43,2 -74.45% | -36,1 -41,2 12.3% | -61,7 -44,1 -40.04% | -42,6 | -30,0 | -26,4 | -25,9 | -19,7 |
|
EPS USD | Released Forecast Spread | -0,10 -0,31 67.87% | -0,40 -0,37 -7.54% | -0,32 -0,35 9.09% | -0,23 -0,30 22.25% | -0,38 -0,19 -98.26% | -0,28 -0,31 8.79% | -0,40 -0,23 -73.08% | -0,19 -0,24 20.83% | -0,31 -0,25 -26.29% | -0,21 | -0,15 | -0,13 | -0,12 | -0,09 |
| Announcement Date | 23/02/22 | 05/05/22 | 04/08/22 | 01/11/22 | 21/02/23 | 03/05/23 | 03/08/23 | 02/11/23 | 26/02/24 | - | - | - | - | - |
More events
Past sector events for BioCryst Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BCRX Stock
- Calendar BioCryst Pharmaceuticals, Inc.
